COVID Breath Test - Ancon

Breath Test Feasibility Trial for COVID-19 Infection Diagnosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04760639

Enrollment

100

Registered

2021-02-18

Start date

2020-12-16

Completion date

2022-09-20

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.

Interventions

DIAGNOSTIC_TESTBreath test

Participants provide a breath sample

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 18 years and older * Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.

Exclusion criteria

* Unable to consent * Patients on a ventilator * Pregnant Women

Design outcomes

Primary

Measure	Time frame	Description
Provide an adequate sample and compare the signals given from the two groups.	10 minutes	The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026